Halifax-Backed Envision Pharma Expands Into Asia-Pacific Via ProScribe Acquisition

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WASHINGTON & HORSHAM, United Kingdom--(BUSINESS WIRE)--Envision Pharma Group, a global technology and scientific communication company, announced today that it has acquired Queensland, Australia-based ProScribe, a medical writing company. The acquisition will be Envision’s first in the Asia-Pacific region. Terms of the transaction were not disclosed. The Halifax Group (“Halifax”), a leading private equity firm, initially partnered with Envision Pharma and its management team in June 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news